Join Biopharma Industry Leaders at iiBIGM’s Global Clinical Trial Partnerships Forum

NEW YORK, NY--(Marketwire - November 10, 2009) -

Highlighted Links

Conference Overview

To Register

iiBIG and the newly formed Global Biopharmaceutical Advisory Board have jointly planned an event that will focus on one of the most dynamic trends in the pharmaceutical, biotechnology, and medical device industries -- strategic outsourcing. Biopharma CEOs, VPs of Global Operations, and Department Heads will meet at the 4th Annual Global Clinical Trial Partnerships, March 1-2, 2010, in Princeton, New Jersey to discuss the latest strategies for optimizing global operations.

Key issues to be addressed include:

--  Ensuring competitive advantage through proven outsourcing strategies
--  Understanding the latest global regulatory updates in pharma and
    medical device directives
--  Sharing lessons learned to overcome multi-regional operational
    challenges
--  Tackling the latest operational, regulatory and ethical issues in
    emerging markets: Pan-Asia, India, China, and Latin America
--  Obtaining proven tools and techniques for successful patient
    recruitment
    

To address these issues, an outstanding speaking faculty of senior-level executives along with key operational leaders who handle global outsourcing and alliance management has been secured for this conference. Hear from representatives of large, medium, and small pharmaceutical as well as biotechnology and medical device companies as they share their insights on strategies for optimizing clinical operations and outsourcing. Some key faculty speakers include:

-- Luis Rios-Nogales, MD, PhD, MBA, Regional Medical Director ISMO Latin
   America Head, MCCD Clinical Research Region, AstraZeneca Latin America

-- Christopher C. Gallen, MD, PhD, President and CEO, Neuromed
   Pharmaceuticals Inc.

-- Ross D.  Pettit, Vice President Operations, ARIAD Pharmaceuticals

-- Christina DiArcangelo, Associate Director, Clinical Contracts and
   Outsourcing, Department Head, FibroGen, Inc.

-- Raymond Panas, PhD, Director of International Clinical Development,
   Sucampo Pharmaceuticals

-- Fidela Moreno, MD, Vice President Global Development, Clinical Site
   Management & Monitoring, Allergan

For complete information about this event visit: www.iibig.com/P1001

About iiBIG

iiBIG (International Institute for Business Information & Growth) is an unbiased, independent company dedicated to organizing business-to-business conferences and seminars for senior-level business executives. We provide learning and networking settings for some of the business community forward thinkers -- those who occupy the highest levels in their companies and organizations. Our events focus on the most pressing and timely issues facing decision-makers in today's global economy. For more information, visit: http://www.iibig.com.